同和药业 (300636.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(同和药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 187,881,813.70175,596,611.66206,454,983.02162,476,835.68177,907,849.05161,007,542.01220,746,478.69
 营业收入(元) 187,881,813.70175,596,611.66206,454,983.02162,476,835.68177,907,849.05161,007,542.01220,746,478.69
二、营业总成本(元) 160,009,184.85144,506,458.72150,662,133.88123,579,933.06149,783,635.28147,572,839.12178,963,287.50
 营业成本(元) 127,952,611.70119,383,459.99130,754,859.2197,092,123.59130,065,180.25112,978,933.47141,521,794.43
 研发费用(元) 17,022,720.7011,889,403.8810,292,403.0515,673,891.688,948,750.2619,318,432.0819,210,151.13
 营业税金及附加(元) 1,989,311.042,532,587.79859,073.90860,377.961,057,206.11876,095.52869,458.08
 销售费用(元) 6,013,560.836,734,856.935,925,788.938,694,346.945,724,067.496,536,417.765,300,263.91
 管理费用(元) 9,414,304.739,046,477.628,397,949.836,612,785.728,908,278.499,988,611.719,060,867.23
 财务费用(元) -2,383,324.15-5,080,327.49-5,567,941.04-5,353,592.83-4,919,847.32-2,125,651.423,000,752.72
  其中:利息费用(元) 4,264,878.764,849,643.564,062,134.723,729,702.551,754,251.482,972,491.831,438,946.07
  其中:利息收入(元) 6,897,739.207,203,036.239,013,826.298,106,821.006,164,227.941,636,205.571,103,322.22
 资产减值损失(元) -460,666.26-3,993,632.55-7,920,742.47-18,149,444.561,502,811.203,067,894.32-5,564,343.65
 信用减值损失(元) 127,250.00537,565.68-2,525,755.021,580,012.83-1,067,964.121,162,765.19-1,567,475.50
三、其他经营收益
 加:投资收益(元) 652,589.44------
 资产处置收益(元) ----432,461.43---
 其他收益(元) 611,398.351,293,953.863,685,602.25549,970.98415,172.658,449,984.26366,757.74
四、营业利润(元) 28,803,200.3828,176,012.4149,031,953.9023,012,859.3928,085,922.1126,115,346.6635,018,129.78
 加:营业外收入(元) ---347,354.24--6,725.66
 减:营业外支出(元) 446,160.72-66,750.0020,000.00--65,990.00
五、利润总额(元) 28,357,041.0228,176,012.4148,965,203.9023,340,213.6328,085,922.1126,115,346.6634,958,865.44
 减:所得税费用(元) 2,172,601.822,186,741.155,402,452.76-3,989,875.666,463,586.962,180,988.691,862,390.70
六、净利润(元) 26,184,439.2025,989,271.2643,562,751.1427,330,089.2921,622,335.1523,934,357.9733,096,474.74
(一)按经营持续性分类
  持续经营净利润(元) 26,184,439.20--27,330,089.2921,622,335.1523,934,357.9733,096,474.74
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 26,184,439.2025,989,271.2643,562,751.1427,330,089.2921,622,335.1523,934,357.9733,096,474.74
 扣除非经常性损益后的净利润(元) 25,535,011.6827,038,639.8040,487,634.0426,506,080.8722,024,503.0716,774,254.0032,834,366.16
七、每股收益
 一、基本每股收益(元) 0.060.060.100.060.050.070.09
 二、稀释每股收益(元) 0.060.060.100.060.050.070.09
九、综合收益总额(元) 26,184,439.2025,989,271.2643,562,751.1427,330,089.2921,622,335.1523,934,357.9733,096,474.74
 归属于母公司所有者的综合收益总额(元) 26,184,439.2025,989,271.2643,562,751.1427,330,089.2921,622,335.1523,934,357.9733,096,474.74
公告日期 2024-10-242024-08-292024-04-252024-04-252023-10-262023-08-292023-04-24
审计意见(境内) 标准无保留意见

前瞻产业研究院